|Status : Upcoming||Report Code : VRHC1061||Industry : Healthcare||Available Format :|
Cerebrospinal fluid (CSF) management is clear and colorless body fluid found in the brain and spine which acts as a support for the brain, providing basic mechanical and immunological protection to the brain inside the skull. The global cerebrospinal fluid management market is growing at significant rate, due to mounting occurrence hydrocephalus and expanding geriatric population. Different product contributed to the cerebrospinal fluid management market size. The market has witnessed high demand for shunts in the coming years due to mounting number of shunting procedures and expanding geriatric population.
Insight by Product
On the basis of product the cerebrospinal fluid management market is subdivided into external drainage systems and shunts. Of all products, shunts segment accounted the largest share and is expected to grow at fastest rate in the market due to mounting number of shunting procedures, expending geriatric population and mounting number of revision shunt surgeries due to infection or shunt malfunction. Shunts are used for the alteration of CSF in a controlled way from the central nervous system (CNS) fluid compartments.
On the basis of type the shunts market is further subdivided into ventriculoperitoneal (VP) shunts, lumboperitoneal (LP) shunts, ventriculoatrial (VA) shunts and ventriculopleural (VPL) shunts. Moreover, on the basis of valve type shunts market is further subdivided into fixed valve shunts and adjustable valve shunts. In addition, the external drainage system is further subdivided into external ventricular drainage (EVD) systems and lumbar drainage (LD) systems.
Insight by End User
The different end users of the market are adult, pediatric and geriatric. Mounting occurrence of congenital hydrocephalus and escalating number of shunting procedures in the pediatric population are the factors growing the demand of cerebrospinal fluid management in pediatrics. Among the all end users, the pediatric segment accounted the largest share and is expected to grow at fastest rate in the cerebrospinal fluid management market.
Mounting number of shunting procedures, quick advancements in continuing research projects associated to brain barriers and fluids, mounting occurrence of neurological disorders, and mounting occurrence of hydrocephalus are the primary growth drivers for cerebrospinal fluid management market. For instance, according to Hydrocephalus Association, more than 1,000,000 people in the U.S. live with hydrocephalus.
Mounting healthcare spending, expanding geriatric population, increasing awareness about neurological diseases and refining healthcare infrastructure in developing economies are also facilitating the growth for the cerebrospinal fluid management market. For instance, according to World Health Organization (WHO), globally in 2010 approximately 524 million people were aged 65 years and older, and is expected to reach 1.5 billion in 2050.
Lack of skilled professionals and high cost of shunts are the major challenges for the growth of cerebrospinal fluid management market. Complications associated with CSF shunts are hindering the growth of the cerebrospinal fluid management market. For instance, shunt malfunction, shunt infection, under drainage, subdural hematoma, seizures, multiloculated hydrocephalus and over drainage are the complications associated with the CSF shunts.
Globally, the manufacturing companies trying to enter the cerebrospinal fluid management market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.
Geographically, North America is the largest cerebrospinal fluid management market as in the region the occurrence of hydrocephalus increasing. Mounting funding for hydrocephalus research, mounting occurrence of neurological disorders, expanding geriatric population, mounting demand for minimally invasive procedure, rapid technological advancement and the initiate of organizations are also up surging growth of the North American cerebrospinal fluid management market. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.
Asia-Pacific is observed to witness fastest growth in the market, due to mounting occurrence of hydrocephalus and increasing awareness about neurological diseases. In addition, improving healthcare infrastructure, mounting medical tourism, mounting demand for minimally invasive procedure, mounting occurrence of stroke disease, expanding geriatric population and mounting healthcare expenditure are also creating a positive impact on the cerebrospinal fluid management market growth in the region.
Key players in the cerebrospinal fluid management market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2016, Medtronic PLC, received FDA clearance for StrataMR valves and shunts, for treatment of patients with hydrocephalus and cerebrospinal fluid disorders.
In addition, in April 2017, Medtronic PLC, voluntary recalls all unused StrataMR valves and shunts. Medtronic PLC, Spiegelberg GmbH & Co. Kg, Deltasurgical, Integra Lifesciences Holdings Corporation, Natus Medical Incorporated, G.SURGIWEAR LTD, B. Braun Melsungen, Dispomedica GmbH, SOPHYSA, Moller Medical GmbH, and Wellong Instruments Co., Ltd are the key players offering cerebrospinal fluid management.